Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-04

Clinical Trial Update: Double-Blind Naltrexone in Kleptomania [Phase 2]

View source ↗

Summary

A Phase 2 double-blind trial evaluating naltrexone for kleptomania has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: University of Minnesota | Conditions: Kleptomania | Phase 2 | Status: COMPLETED | Results posted: 2012-05-04